ERAS in Liver Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

126 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Enhanced Recovery After Surgery (ERAS) Program (EP) is widely applied to obtain a reduction in post-operative length of hospital stay and a faster restoration of pre-operative patient conditions. However, in Western countries, adherence to EP in liver surgery is still difficult to achieve due to deep-rooted traditional practices. In our Institute, since 2019, EP has been applied pursuing 18/23 items identified by 2016 guidelines. At all consecutive patients who underwent elective liver surgery in our Institution, EP was proposed and their adherence to ERAS items was measured before, during and after surgery. Data were retrospectively collected and analysed, particularly focusing on EP items. Primary outcome was compliance to EP, defined as at least 80% of accomplished items per patient. Secondary outcome was adherence to each ERAS item, while tertiary outcome was detecting the variables associated with program drop out.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy

NCT02533193

Liver Diseases

COMPLETED NA

Enhanced Recovery After Hepatic Surgery (MultiPAS).

NCT02715427

Liver Surgery

UNKNOWN NA

Transitional ePRO Diary Liver

NCT06342557

Liver Transplant

RECRUITING

Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection

NCT04100304

Liver Diseases

UNKNOWN NA

Complicated Outcome Prediction After Liver Resection

NCT03577067

Liver Neoplasms

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ERAS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ERAS-in

Patients who completed ERAS program

Liver resection

Intervention Type PROCEDURE

Liver resection, different kind of according to pathology

ERAS-out

Patients who dropped-out from ERAS program

Liver resection

Intervention Type PROCEDURE

Liver resection, different kind of according to pathology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liver resection

Liver resection, different kind of according to pathology

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients candidates to surgery for benign or malignant liver disease
* liver resection with curative intent

Exclusion Criteria

* refusal to participate at the EP
* incapability to acquire informed consent
* cognitive impairment that can prejudice the patient comprehension of the EP
* liver surgery with palliative or diagnostic intent or non-resective liver surgery
* emergency surgery

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No